China Resources Pharmaceutical Group Limited

HK$4.67As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3320Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (3.86%)
Div yield 4.85%
ROE 8.32%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.47)
PE TTM 6.110
TSR TTM (1.24%)
Mkt cap HK$29.31B
ROIC 5.99%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.52
(3.07%)
(46.34%)
Hold 2|6|12|6|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.05
0.04
0.05
12.16%
8.93%
7.28%
7.70%
Revenue¥B
1.983
1.981
2.053
2.133
14.14%
8.17%
11.76%
12.59%
Peers (US$3.738B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.945
(0.056)
(0.053)
EBIT/Intx
0.836
0.139
0.105
Own earn%
21.57
(127.89)
(107.43)
Sh yield%
31.45
44.36
42.82
Owners
Insiders/Inst%
8.67
65.29
Short interest%
3.78
SBC / revenue%
0.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
13–18
$1 testx
0.0
Incr. ROIC%
4